Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Adverse Events During ART and Implications for Treatment: Key Data From Summer 2021
  • CME
  • CE

Eric S. Daar, MD
Released: September 22, 2021
Back Next


Eric S. Daar, MD:
This Clinical Focus module will center on emerging insights about adverse events (AEs) during antiretroviral therapy (ART) and implications for treatment, with a focus on data from the 11th International AIDS Society Conference on HIV Science (IAS 2021).

We will look at AEs that may be unique to given drugs and those that may be relevant across many therapeutics, such as metabolic parameters, particularly lipid abnormalities; insulin resistance; and—of importance—weight changes.

We generally obtain this information from randomized, controlled trials of patients who are treatment naive and initiating first-line ART or, increasingly, patients switching from a stable ART regimen to a new regimen. I will discuss studies of both first-line and treatment-switching scenarios to better understand how specific drugs and/or changes in regimens may impact some of these potential AEs.

The slide thumbnails in this activity link to a complete PowerPoint slideset that can be found here or downloaded by clicking any of the thumbnails within the activity. 

Clinical Care Options plans to measure the educational impact of this activity, and some questions will be asked twice: once before the discussion that informs the best choice and again after that specific discussion. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings